Opthea Ltd(OPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OPT Opthea Ltd

交易中 12-23 13:29:48 EST

3.46

+0.11

+3.28%

最高3.60	最低3.35	成交量5,132
今开3.35	昨收3.35	日振幅7.46%
总市值5.32亿	流通市值3.34亿	总股本1.54亿
成交额1.79万	换手率0.01%	流通股本9,665万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OPT","market":"US","secType":"STK","nameCN":"Opthea Ltd","latestPrice":3.46,"timestamp":1734978180519,"preClose":3.35,"halted":0,"volume":5132,"delay":0,"floatShares":96646852,"shares":153886827,"eps":-2.760792,"marketStatus":"交易中","marketStatusCode":2,"change":0.11,"latestTime":"12-23 13:29:48 EST","open":3.35,"high":3.6,"low":3.35,"amount":17931.3275756,"amplitude":0.074627,"askPrice":3.64,"askSize":527,"bidPrice":3.45,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-2.760792,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1602820800000,"adjPreClose":3.35,"adrRate":8,"preHourTrading":{"tag":"盘前","latestPrice":3.46,"preClose":3.35,"latestTime":"08:08 EST","volume":200,"amount":692,"timestamp":1734959332575},"postHourTrading":{"tag":"盘后","latestPrice":3.35,"preClose":3.3401,"latestTime":"16:00 EST","volume":5,"amount":16.75,"timestamp":1734728401575},"volumeRatio":0.934272},"requestUrl":"/m/hq/s/OPT","defaultTab":"news","newsList":[{"id":"2493976601","title":"Opthea Limited盘中异动 早盘急速上涨7.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493976601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493976601?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:50","pubTimestamp":1734965435,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时50分，Opthea Limited股票出现异动，股价大幅上涨7.78%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.20%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223225035ab8e49da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223225035ab8e49da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2493072424","title":"Opthea Limited盘中异动 大幅上涨5.73%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493072424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493072424?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:48","pubTimestamp":1734716933,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时48分，Opthea Limited股票出现异动，股价快速上涨5.73%。截至发稿，该股报3.42美元/股，成交量9974股，换手率0.01%，振幅2.79%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.85%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101485395ea9f49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101485395ea9f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2492362172","title":"Opthea Limited盘中异动 早盘快速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492362172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492362172?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:58","pubTimestamp":1734620285,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时58分，Opthea Limited股票出现异动，股价急速上涨5.06%。Opthea Limited股票所在的生物技术行业中，整体跌幅为3.44%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219225805a1fb63e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219225805a1fb63e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2492960527","title":"Opthea Limited盘中异动 股价大跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492960527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492960527?lang=zh_cn&edition=full","pubTime":"2024-12-18 00:50","pubTimestamp":1734454258,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日00时50分，Opthea Limited股票出现波动，股价快速下跌5.57%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.83%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218005058984c928b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218005058984c928b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2490733386","title":"Opthea Limited盘中异动 早盘大幅跳水6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490733386","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490733386?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:38","pubTimestamp":1734017886,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时38分，Opthea Limited股票出现异动，股价急速下跌6.16%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.82%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212233807a1e970ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212233807a1e970ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2490899295","title":"Opthea Limited盘中异动 下午盘大幅下挫5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490899295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490899295?lang=zh_cn&edition=full","pubTime":"2024-12-12 02:31","pubTimestamp":1733941919,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日02时31分，Opthea Limited股票出现波动，股价急速下跌5.74%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.14%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212023159a1e6db19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212023159a1e6db19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0},{"id":"2489112407","title":"Opthea Limited盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489112407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489112407?lang=zh_cn&edition=full","pubTime":"2024-12-05 01:25","pubTimestamp":1733333145,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日01时25分，Opthea Limited股票出现异动，股价快速下跌5.19%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.43%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120501254598e5647a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120501254598e5647a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2487762550","title":"Opthea Limited盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487762550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487762550?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:31","pubTimestamp":1732890685,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时31分，Opthea Limited股票出现波动，股价急速上涨5.11%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.12%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922312598e46640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922312598e46640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2484275676","title":"Opthea Limited盘中异动 股价大涨5.56%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484275676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484275676?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:46","pubTimestamp":1731941166,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时46分，Opthea Limited股票出现波动，股价快速上涨5.56%。截至发稿，该股报3.42美元/股，成交量1163股，换手率0.00%，振幅4.01%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.19%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224606abccb47d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224606abccb47d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2483054653","title":"Opthea Limited盘中异动 急速下挫6.05%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483054653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483054653?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:36","pubTimestamp":1731684982,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时36分，Opthea Limited股票出现波动，股价快速下跌6.05%。截至发稿，该股报3.18美元/股，成交量1.2378万股，换手率0.01%，振幅3.99%。Opthea Limited股票所在的生物技术行业中，整体跌幅为3.36%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115233623abc508d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115233623abc508d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2483833024","title":"Opthea Limited盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483833024?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:57","pubTimestamp":1731513427,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时57分，Opthea Limited股票出现波动，股价快速下跌5.48%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.09%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113235708abbe0c06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113235708abbe0c06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2478548196","title":"Opthea Limited盘中异动 早盘大幅上涨6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478548196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478548196?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:30","pubTimestamp":1730122225,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时30分，Opthea Limited股票出现波动，股价大幅上涨6.47%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Revance Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为534.84%、47.79%、35.84%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、Okyo Pharma Ltd Com Npv 、Avid Bioservices, Inc.，振幅分别为4.31%、3.97%、3.90%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213026a1f24c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213026a1f24c45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0},{"id":"2477637437","title":"Opthea Limited盘中异动 股价大跌5.50%报4.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477637437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477637437?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:03","pubTimestamp":1729778622,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时03分，Opthea Limited股票出现波动，股价快速下挫5.50%。截至发稿，该股报4.29美元/股，成交量3250股，换手率0.00%，振幅3.66%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.61%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422034298e3e42a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422034298e3e42a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2477583337","title":"Opthea Limited盘中异动 急速下挫7.03%报4.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477583337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477583337?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:31","pubTimestamp":1729603866,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时31分，Opthea Limited股票出现异动，股价急速下挫7.03%。截至发稿，该股报4.63美元/股，成交量9313股，换手率0.01%，振幅4.62%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.29%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221310698e3dc2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221310698e3dc2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2475836745","title":"Opthea Limited盘中异动 早盘快速上涨6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475836745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475836745?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:31","pubTimestamp":1728912669,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时31分，Opthea Limited股票出现异动，股价快速上涨6.24%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.08%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014213109971a0143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014213109971a0143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT"],"gpt_icon":0},{"id":"2474011573","title":"Opthea Limited盘中异动 临近午盘快速上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474011573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474011573?lang=zh_cn&edition=full","pubTime":"2024-10-11 23:43","pubTimestamp":1728661412,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日23时43分，Opthea Limited股票出现异动，股价急速上涨5.32%。截至发稿，该股报4.95美元/股，成交量1.877万股，换手率0.01%，振幅3.19%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.95%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。该公司正在开发一种新型生物疗法 OPT-302，用于治疗眼病。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011234332ab697745&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011234332ab697745&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2473438121","title":"Opthea Limited盘中异动 临近收盘大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473438121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473438121?lang=zh_cn&edition=full","pubTime":"2024-10-08 03:47","pubTimestamp":1728330457,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日03时47分，Opthea Limited股票出现异动，股价大幅拉升5.13%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.10%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008034737ab68252f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008034737ab68252f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0},{"id":"2472642974","title":"Opthea Limited盘中异动 股价大跌5.87%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472642974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472642974?lang=zh_cn&edition=full","pubTime":"2024-10-04 02:16","pubTimestamp":1727979418,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日02时16分，Opthea Limited股票出现异动，股价大幅下挫5.87%。截至发稿，该股报4.33美元/股，成交量3.7891万股，换手率0.02%，振幅6.96%。Opthea Limited股票所在的生物技术行业中，整体跌幅为1.83%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004021659a1de2c49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004021659a1de2c49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2472375935","title":"Opthea Limited盘中异动 早盘快速上涨5.65%报4.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472375935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472375935?lang=zh_cn&edition=full","pubTime":"2024-10-01 21:33","pubTimestamp":1727789606,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日21时33分，Opthea Limited股票出现波动，股价急速上涨5.65%。截至发稿，该股报4.30美元/股，成交量1588股，换手率0.00%，振幅2.46%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.24%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100121332798e39ee3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100121332798e39ee3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0},{"id":"2470503338","title":"Opthea Limited盘中异动 急速下挫9.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470503338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470503338?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:25","pubTimestamp":1727450753,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时25分，Opthea Limited股票出现异动，股价大幅下挫9.75%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3922.77%、212.91%、124.07%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为167.75%、61.38%、51.58%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092723255398e3970a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092723255398e3970a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.opthea.com","stockEarnings":[{"period":"1week","weight":0.0277},{"period":"1month","weight":0.0183},{"period":"3month","weight":-0.1584},{"period":"6month","weight":0.6701},{"period":"1year","weight":0.2996},{"period":"ytd","weight":0.1322}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Opthea Limited于1984年根据澳大利亚法律注册成立，名称为Circadian Technologies Limited。该公司是一家临床阶段生物制药公司，致力于开发一种新型疗法，用于治疗高度流行和进行性视网膜疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.029364},{"month":2,"riseRate":0.25,"avgChangeRate":-0.045322},{"month":3,"riseRate":0.75,"avgChangeRate":0.041409},{"month":4,"riseRate":0.25,"avgChangeRate":-0.067705},{"month":5,"riseRate":0.25,"avgChangeRate":-0.018043},{"month":6,"riseRate":0,"avgChangeRate":-0.185643},{"month":7,"riseRate":0.75,"avgChangeRate":0.050972},{"month":8,"riseRate":0.5,"avgChangeRate":0.036823},{"month":9,"riseRate":0.75,"avgChangeRate":0.035487},{"month":10,"riseRate":0.25,"avgChangeRate":-0.057655},{"month":11,"riseRate":0.6,"avgChangeRate":0.060069},{"month":12,"riseRate":0.6,"avgChangeRate":0.025364}],"exchange":"NASDAQ","name":"Opthea Ltd","nameEN":"Opthea Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Opthea Ltd(OPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Opthea Ltd(OPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Opthea Ltd,OPT,Opthea Ltd股票,Opthea Ltd股票老虎,Opthea Ltd股票老虎国际,Opthea Ltd行情,Opthea Ltd股票行情,Opthea Ltd股价,Opthea Ltd股市,Opthea Ltd股票价格,Opthea Ltd股票交易,Opthea Ltd股票购买,Opthea Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Opthea Ltd(OPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Opthea Ltd(OPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}